Special Issue "New Antimalarial Drugs"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 November 2010)
Prof. Dr. Paul D. Roepe
Department of Chemistry, Department of Biochemistry and Molecular Biology, and Program in Tumor Biology, Lombardi Cancer Center, Georgetown University, 3900 Reservoir Rd. NW, Washington, DC 20057, USA
Dr. Derek J. McPhee
Director of Chemistry, Amyris Biotechnologies, Inc., 5885 Hollis St, Suite 100, Emeryville, CA 94608, USA
Phone: +1 510 450 0761 xt 718
Fax: +1 510 225 2645
Interests: organic synthesis; medicinal chemistry; biotechnology
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
Article: Malaria-Infected Mice Are Cured by a Single Low Dose of a New Silylamide Trioxane Plus Mefloquine
Pharmaceuticals 2009, 2(3), 228-235; doi:10.3390/ph2030228
Received: 24 November 2009; in revised form: 8 December 2009 / Accepted: 18 December 2009 / Published: 21 December 2009| Download PDF Full-text (150 KB) | Download XML Full-text
Pharmaceuticals 2010, 3(7), 2322-2332; doi:10.3390/ph3072322
Received: 28 June 2010; in revised form: 14 July 2010 / Accepted: 20 July 2010 / Published: 21 July 2010| Download PDF Full-text (69 KB)
Pharmaceuticals 2010, 3(12), 3581-3593; doi:10.3390/ph3123581
Received: 15 November 2010; in revised form: 8 December 2010 / Accepted: 9 December 2010 / Published: 14 December 2010| Download PDF Full-text (205 KB)
Review: Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials
Pharmaceuticals 2011, 4(1), 44-68; doi:10.3390/ph4010044
Received: 30 November 2010; in revised form: 14 December 2010 / Accepted: 21 December 2010 / Published: 23 December 2010| Download PDF Full-text (177 KB) | Download XML Full-text
Article: Bioequivalence of Two Intravenous Artesunate Products with Its Active Metabolite Following Single and Multiple Injections
Pharmaceuticals 2011, 4(1), 138-153; doi:10.3390/ph4010138
Received: 29 November 2010; in revised form: 22 December 2010 / Accepted: 5 January 2011 / Published: 7 January 2011| Download PDF Full-text (133 KB) | Download XML Full-text
Pharmaceuticals 2011, 4(5), 681-712; doi:10.3390/ph4050681
Received: 16 January 2011; in revised form: 9 April 2011 / Accepted: 19 April 2011 / Published: 26 April 2011| Download PDF Full-text (246 KB) | Download XML Full-text
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Affiliation: Center for Global Health and Diseases, School of Medicine, Case Western Reserve University, Cleveland, Wolstein Research Building, #4-129, Cleveland, Ohio, USA; E-Mail: email@example.com; (B.T.G.) firstname.lastname@example.org (R.K.M.)
Last update: 7 January 2011